Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia

BACKGROUND: Treatment-refractory schizophrenia (TRS), accounting for approximately 30% of all schizophrenia cases, has poor treatment response and prognosis despite treatment with antipsychotic drugs. AIM: To analyze the therapeutic effectiveness of repetitive transcranial magnetic stimulation (rTMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin-Ling, Tan, Zhi-Mei, Jiao, Shu-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401498/
https://www.ncbi.nlm.nih.gov/pubmed/37547736
http://dx.doi.org/10.5498/wjp.v13.i7.453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401498/
https://www.ncbi.nlm.nih.gov/pubmed/37547736
http://dx.doi.org/10.5498/wjp.v13.i7.453

Ejemplares similares